US President Donald Trump's latest medical summary has ignited a debate over White House transparency after a medication previously listed in official records failed to appear in last week's documentation.
The omission concerns finasteride, a widely used treatment for male-pattern baldness, and has prompted immediate discussion among medical experts regarding the accuracy and completeness of the health disclosures surrounding the 79-year-old President.